Early-stage research will be conducted, and 100 employees will be added.
AMRI opened its $8 million, 50,000 sq. ft. R&D center in Hyderabad, India. The facility includes laboratories for conducting early-stage research such as custom chemical synthesis and analytical chemistry.
During this first phase of expansion, the R&D building will add approximately 100 employees to AMRI’s operations at this location, which currently has 35 scientists. The company reports that infrastructure is in place that will allow it to add a second facility, which would more than double employee headcount.
Also, scale-up laboratories for preparing both preclinical and clinical trial supply active ingredients are expected to open later this year and 2008, respectively, according to AMRI.
AMRI states that the opening marks another milestone in the company’s global expansion. In May, AMRI acquired two pharmaceutical manufacturing sites, along with additional land for expansion, in Aurangabad and Navi Mumbai, India. “We look forward to achieving synergies between these new development laboratories and our large-scale manufacturing facilities,” remarks Thomas E. D’Ambra, Ph.D., chairman, CEO, and president.
